Latest:
Fighting Cancer Is Enough, You Don't Have to Do More
- About Us
- Advertise / Support
- Editorial Board
- Contact Us
- CancerNetwork.com
- TargetedOnc.com
- OncLive.com
- OncNursingNews.com
- Terms & Conditions
- Privacy
- Do Not Sell My Information
© 2025 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Contributors
Dr. Armine Smith
Dr. Armine Smith is a Urologist at Johns Hopkins University, the director of urologic oncology at Sibley Memorial Hospital, and co-director for women's bladder cancer program at Johns Hopkins University and Greenberg Bladder Cancer Institute.
Latest:
Robotic Kidney Cancer Surgery May Aid Recovery, Spare Kidney Function
Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, according to Dr. Armine Smith.
Dr. Guru Sonpavde
Dr. Guru Sonpavde, the medical director of Genitourinary Oncology, an assistant director of the Clinical Research Unit, and the Christopher K. Glanz Chair for Bladder Cancer Research at the AdventHealth Cancer Institute, located in Orlando, Florida.
Latest:
Breaking Down the CheckMate 901 Trial Data for Metastatic Bladder Cancer
Dr. Guru Sonpavde discusses the CheckMate 901 trial evaluating Opdivo plus Yervoy for those with cisplatin-ineligible, metastatic urothelial carcinoma.
Chuck Stravin
Chuck Stravin is based in Quincy, Massachusetts. He is a Kidney Cancer Patient Advocate & Living with Advanced Stage 4 Renal Cell Cancer.
Latest:
Finding Strength and Joy During My Stage 4 Kidney Cancer Experience
Living with stage 4 kidney cancer has taught me to embrace the present, cherish connection and find gratitude each day in unexpected places.
Dr. Alan Tan
Dr. Alan Tan is a GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Naashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer at the Alliance for Clinical Trials in Oncology.
Latest:
ctDNA Testing May Offer Patients With RCC ‘Peace of Mind’
Dr. Alan Tan explores circulating tumor DNA, its role in clinical trials and its potential impact on patients with renal cell carcinoma.
Dr. Debu Tripathy
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston.
Latest:
The Power of Knowledge and Staying Informed in Breast Cancer Care
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Sony Tuteja
Sony Tuteja is director of Pharmacogenomics at the Penn Medicine Center for Genomic Medicine and a research assistant professor of Translational Medicine and Human Genetics
Latest:
Why Genetic Testing Matters for Patients with Gastrointestinal Cancers
Genetic testing before chemotherapy may help improve safety and guide treatment for patients with gastrointestinal cancers.